Cochrane Abstracts
Oral zinc for the prevention of hyperbilirubinaemia in neonates New
Oral zinc for the prevention of hyperbilirubinaemia in neonates New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Zinc for the Prevention of Hyperbilirubinaemia in Neonates New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New. Accessed 31 January 2023.
Oral zinc for the prevention of hyperbilirubinaemia in neonates New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New. Accessed January 31, 2023.
Oral zinc for the prevention of hyperbilirubinaemia in neonates New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New
Oral Zinc for the Prevention of Hyperbilirubinaemia in Neonates New [Internet]. In: Cochrane Abstracts. [cited 2023 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral zinc for the prevention of hyperbilirubinaemia in neonates New
ID - 439073
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439073/all/Tocilizumab_for_thyroid_eye_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -
